News

The study treatments include clevudine 30mg/day, tenofovir 300mg/day or the combination of both drugs administered to 150 treatment-naive hepatitis B e-antigen negative hepatitis B virus (HBV)-infected patients for

The company’s decision is based on the following: lack of clinically significant antiviral effects at the doses tested to date as a single therapy; and availability of very

Under the terms of the agreement, InSight will provide magnetic resonance imaging services at four County-owned academic medical centers: Harbor-UCLA, Martin Luther King, Jr/Drew Medical Center, Olive View-UCLA

The parties expect to complete the merger in the fourth quarter of 2008, however, the actual timing of the transaction will depend on a number of factors, some

In addition, Digestive Care has recently completed a randomized, double-blind, placebo-controlled, multi-center, crossover study on Pancrecarb MS-16. The clinical trial was conducted at five centers and included 21

Cognitive function was significantly improved over placebo (p=0.03) as measured by the mini-mental state examination (MMSE), the cognition scale most widely used by clinicians to assess patients with

In addition, St Jude Medical announced the final allocation of cash and stock to EP MedSystems shareholders in connection with the acquisition. As previously announced, under the terms

The company expects Mr Freiman to continue to serve on the board. Mr Freiman is the former CEO of Syntex of Palo Alto, California. Mr Freiman is retiring

Mr Prentki succeeds Gregory Turnbull, who will remain a company director, a member of the board’s executive committee and, until a permanent successor is recruited, interim CFO. Mr